← SynDRA
ABEQUOLIXRON
SynDRA canonical compound SYN0020168 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NR1H2 | NR1H3 |
|---|
| Mechanism of action | LXR agonist |
|---|
All known targets
Mechanisms of action (all sources)
- NR1H3 AGONIST
- Liver X receptor agonist
- NR1H2 AGONIST
- LXR agonist
Cross-references
Synonyms
- RGX-104
- SB-742881
- Rgx-104 hydrochloride
- UNII-D32013XLTX
- SCHEMBL3975944
- D32013XLTX
- LCMIYQOJZLRHTO-GJFSDDNBSA-N
- (r)-2-(3-{3-[[2chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-3-methyl-propoxy}-phenyl)acetic acid hydrochloride salt
- SB 742881
- Q26B92650V
- RGX104
- RefChem:1075138
- LXR-b Agonist RGX-104
- Liver X Receptor beta Agonist RGX-104
- RGX-104 free Acid
- Abequolixron [USAN]
- RGX104 Free Acid
- RGX-104 free form
- RGX-104 free Acid?
- SB742881
- UNII-Q26B92650V
- WHO 11555
- RGX-104 free form?
- Abequolixron (USAN/INN)
- ABEQUOLIXRON [INN]
- C34H33ClF3NO3
- ABEQUOLIXRON [WHO-DD]
- orb1299525
- SCHEMBL3976801
- SCHEMBL29375119
- ZLJZDYOBXVOTSA-XMMPIXPASA-N
- KZA31854
- BDBM50300575
- NSC813859
- AKOS037649209
- HY-111498A
- NSC-813859
- SB 742881; RGX-104 free form
- BS-17201
Look up ABEQUOLIXRON in the interactive SynDRA portal →